Atrion Corporation Receivables Turnover Ratio (ATRI), from the second quarter 2024 to the second quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Atrion Corporation  (NASDAQ: ATRI)
 

Atrion Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Atrion Corporation's ability to collect accounts receivable sequentially worsen to 7.41, indicating more challenging environment then in the first quarter 2024, but still, it is a far cry from any concerns. Average collection period, for Atrion's accounts receivable remained unchanged at 49 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 188 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 1555 to 1656.

What is Receivable Turnover Ratio?
What is Atrion Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRI Receivables Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Receivable Change 12.08 % 29.3 % 6368.82 % 5.68 % -13.97 %
Y / Y Revenue Change 11.26 % 18.36 % 1.7 % -6.09 % -10.32 %
Receivable Turnover Ratio (TTM) 7.41 7.43 7.57 10.1 10.46
ATRI's Total Ranking # 1656 # 1555 # 1722 # 1327 #
Accounts Receivable average collection period days 49 49 48 36 35
Seq. Receivable Change 5.73 % 9.06 % -1.12 % -1.7 % 21.98 %
Seq. Revenue Change 3.04 % 8.6 % 3.99 % -4.4 % 9.61 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 85
Healthcare Sector # 189
Overall Market # 1656

Receivable Turnover Ratio Statistics
High Average Low
0.9 0.73 0.54
(Dec 31 2015)   (Mar 31 2021)





ATRI Company Profile • Back to ATRI Efficiency Comparisons • Compare ATRI Receivables Turnover Ratio to its Competitors

Financial Statements
Atrion's Accounts Receivable $ 27 Millions Visit ATRI's Balance sheet
Atrion's Sales TTM $ 182 Millions Visit ATRI's Income Statement
Sources of ATRI's Revenues Visit ATRI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ATRI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ATRI's Growth Rates ATRI's Roa ATRI's Inventory Turnover Ratio ATRI's Dividend Comparisons
ATRI's Profitability Ratios ATRI's Roi ATRI's Asset Turnover Ratio ATRI's Dividend Growth
ATRI's Valuation Ratios ATRI's Roe ATRI's Financial Strength Ratios ATRI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Receivable at quarter ending Jun 30 2024
Innovative Eyewear Inc   18.25 $ 1.530  Millions$ 0.084  Millions
Hookipa Pharma inc   18.18 $ 52.163  Millions$ 2.870  Millions
Zomedica Corp   18.12 $ 25.267  Millions$ 1.394  Millions
Jrsis Health Care Corp  17.78 $ 4.516  Millions$ 0.254  Millions
Co diagnostics Inc   17.43 $ 9.137  Millions$ 0.524  Millions
Milestone Scientific Inc   17.23 $ 8.408  Millions$ 0.488  Millions
Scynexis Inc   17.22 $ 9.666  Millions$ 0.561  Millions
Talkspace Inc   16.80 $ 171.081  Millions$ 10.184  Millions
Lineage Cell Therapeutics Inc   16.62 $ 6.186  Millions$ 0.372  Millions
Neuroone Medical Technologies Corp  16.24 $ 3.922  Millions$ 0.242  Millions
Stablecoin Development Corporation  15.69 $ 11.596  Millions$ 0.739  Millions
Scorpius Holdings inc   15.48 $ 9.845  Millions$ 0.636  Millions
Qhslab Inc   15.46 $ 1.613  Millions$ 0.104  Millions
Ethema Health Corporation   15.44 $ 5.269  Millions$ 0.341  Millions
Pulmatrix Inc   15.32 $ 11.392  Millions$ 0.744  Millions
Nutriband Inc   15.31 $ 1.804  Millions$ 0.118  Millions
Nexalin Technology Inc   15.30 $ 0.150  Millions$ 0.010  Millions
Wave Life Sciences Ltd   15.05 $ 110.500  Millions$ 7.344  Millions
Escalon Medical Corp   14.98 $ 11.982  Millions$ 0.800  Millions
Icu Medical Inc  14.86 $ 2,304.822  Millions$ 155.079  Millions
Sangamo Therapeutics Inc   14.69 $ 12.277  Millions$ 0.836  Millions
Medinotec Inc   14.57 $ 5.856  Millions$ 0.402  Millions
Precipio inc   13.94 $ 16.720  Millions$ 1.199  Millions
Igc Pharma Inc   13.66 $ 1.062  Millions$ 0.078  Millions
Embecta Corp   13.58 $ 1,117.000  Millions$ 82.225  Millions
Greenbrook Tms Inc   13.58 $ 116.485  Millions$ 8.576  Millions
Capforce Inc   13.33 $ 1.965  Millions$ 0.147  Millions
Patterson Companies Inc   13.30 $ 6,533.796  Millions$ 491.147  Millions
Biofrontera Inc   13.26 $ 52.984  Millions$ 3.995  Millions
Chemed Corporation  13.12 $ 2,335.557  Millions$ 177.959  Millions

Date modified: 2024-09-15T09:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.